companydata.dkcompanydata.dk

APGAR DANMARK A/S: Financial statements 2020

CVR: 17533533

Source: annual report 2020, Danish Business Authority

01/07/201930/06/2020

APGAR DANMARK A/S (CVR 17533533) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 10,619,059 and a net result of DKK 93,884 compared with DKK 28,134 the year before. That is a decrease of 2.4% compared with the year before. Equity in the 2020 report amounted to DKK 12,520,872. The solvency ratio was 64.5%. The company had 10 employees in the financial year.

Gross Profit
DKK 10,619,059
Profit/Loss
DKK 93,884
Equity
DKK 12,520,872
Total Assets
DKK 19,425,519
Employees
10

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-10.6 mio.94 t.12.5 mio.10
2019-10.9 mio.28 t.12.4 mio.11
2018-10.2 mio.23 t.12.4 mio.11
2017-10.7 mio.-356 t.12.4 mio.10
2016-11.5 mio.247 t.12.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is APGAR DANMARK A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About APGAR DANMARK A/S

APGAR DANMARK A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 1993. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Christian Markussen and Stig Pieler. The board consists of Christian Markussen, Hanne Pieler, Jan Pedersen and Mette Markussen. The company is owned by PIELER GROUP A/S and MARKUSSEN MEDICAL HOLDING ApS. The company has 13 employees (2018). In 2025, the company reported a gross profit of DKK 12,125,986 and a net result of DKK -1,991,044 compared with DKK 21,676 the year before. Equity in the 2025 report amounted to DKK 10,236,447.

Source: annual report 2025, Danish Business Authority